Our mission is to support radiotherapy as a key treatment in the patient care in oncology thanks to our precision medicine tools. 

Our solutions support clinicians in their decision-making process to improve efficacy and safety. Better information on risk-benefit ratio before treatment for every patient will allow the choice of the best therapeutic strategy. 

Last news

Radiosensitivity on a Blood test

Radiosensitivity on a Blood test  July 2017 After intense R&D, Neolys Diagnostics is proud to announce that our R...

BIO2017 – San Diego

BIO2017 – San Diego June 2017 Seeking for sound industrial partners at in North America and Asia, Neolys Diagnostics...

ESTRO 2017 - Vienna

ESTRO 2017 - Vienna May 2017 During the ESTRO (European Society for Radiotherapy and Oncology) Congress in Vienna, Dr ...

All news

Our Technology

Our technology is the result of over ten years of research by the Radiobiology Group. Their work on individual sensitivity have allowed to set up predictive tests. This technology offers a promissing solution, optimizing the efficiency of radiotherapy treatments and preventing toxicity at the same time.

Read more +